FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca

wccwcc
Jun 10, 2025 - 09:00
 0  0
FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca
Merck's shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus.

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0